A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders

Exclusion Criteria

• •1. History of malignancy that has not been in remission for at least 2 years.
• •2. Viral Screening
• •1. Evidence of chronic active or history of hepatitis B virus (HBV).
• •2. Seropositive for human immunodeficiency virus (HIV) antibody.
• •3. History of bone marrow/hematopoietic stem cell or solid organ transplantation.
• •4. Prior treatment with adoptive T-cell therapy or any gene therapy product directed at any target (e.g. CAR T-cell therapy).